Patent details

Basic Information

Publication number:

EP2310041

PCT Application Number:

PCT/EP/2009/057263

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097617765

PCT Publication Number:

WO/2009/150214

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

UNACYLATED GHRELIN AND ANALOGS AS THERAPEUTIC AGENTS FOR VASCULAR REMODELING IN DIABETIC PATIENTS AND TREATMENT OF CARDIOVASCULAR DISEASE

French Title of Invention:

GHRÉLINE NON ACYLÉE ET ANALOGUES EN TANT QU'AGENTS THÉRAPEUTIQUES POUR UN REMODELAGE VASCULAIRE CHEZ DES PATIENTS DIABÉTIQUES ET TRAITEMENT D'UNE MALADIE CARDIOVASCULAIRE

German Title of Invention:

UNACYLIERTES GHRELIN UND ANALOGA ALS THERAPEUTISCHE MITTEL ZUR GEFÄSSREMODELLIERUNG BEI DIABETIKERN UND BEHANDLUNG VON HERZ-KREISLAUF-ERKRANKUNGEN

SPC Number:

Dates

Filing date:

12/06/2009

Grant date:

13/02/2013

EP Publication Date:

13/02/2013

PCT Publication Date:

17/12/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/04/2011

EP B1 Publication Date:

13/02/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/06/2013

Expiration date:

12/06/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/06/2009

 

 

Name:

ALIZE PHARMA

Address:

15, Chemin Du Saquin, Espace Europeen, 69130 Ecully, France (FR)

Inventor

1

Name:

BRIZZI Maria Felice

Address:

Italy (IT)

2

Name:

MUCCIOLI Giampiero

Address:

Italy (IT)

3

Name:

GHIGO Ezio

Address:

Italy (IT)

Priority

Priority Number:

61163 P

Priority Date:

13/06/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/25;

Filing date	Document type	Number of pages